Resultats de la cerca - Terry Gernsheimer

Refinar resultats
  1. 1
    Chronic Idiopathic Thrombocytopenic Purpura: Mechanisms of Pathogenesis

    Chronic Idiopathic Thrombocytopenic Purpura: Mechanisms of Pathogenesis per Terry Gernsheimer

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Thrombopoietin and Platelet Production in Chronic Immune Thrombocytopenia

    Thrombopoietin and Platelet Production in Chronic Immune Thrombocytopenia per David J. Kuter, Terry Gernsheimer

    Publicat 2009
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  3. 3
    Clinical updates in adult immune thrombocytopenia

    Clinical updates in adult immune thrombocytopenia per Michele P. Lambert, Terry Gernsheimer

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  4. 4
    Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura [see comments]

    Pulse cyclophosphamide therapy for refractory autoimmune thrombocytopenic purpura [see comments] per Alex P. Reiner, Terry Gernsheimer, SJ Slichter

    Publicat 1995
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    THE EFFECTS OF LEUKOREDUCED BLOOD TRANSFUSION ON INFECTION RISK FOLLOWING INJURY

    THE EFFECTS OF LEUKOREDUCED BLOOD TRANSFUSION ON INFECTION RISK FOLLOWING INJURY per Avery B. Nathens, Theresa Nester, Gordon D. Rubenfeld, Raminder Nirula, Terry Gernsheimer

    Publicat 2006
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination

    Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination per Andrew J. Portuguese, Cassandra Sunga, Rebecca Kruse‐Jarres, Terry Gernsheimer, Janis L. Abkowitz

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    HemaApp

    HemaApp per Edward Jay Wang, William Li, Doug Hawkins, Terry Gernsheimer, C Norby-Slycord, Shwetak Patel

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  8. 8
    Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance.

    Mechanisms of thrombocytopenia in chronic autoimmune thrombocytopenic purpura. Evidence of both impaired platelet production and increased platelet clearance. per Penny Ballem, Gerald M. Segal, Jon Stratton, Terry Gernsheimer, J W Adamson, Sherrill J. Slichter

    Publicat 1987
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  9. 9
    Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial

    Laboratory predictors of bleeding and the effect of platelet and RBC transfusions on bleeding outcomes in the PLADO trial per Lynne Uhl, Susan F. Assmann, Taye H. Hamza, Ryan W. Harrison, Terry Gernsheimer, Sherrill J. Slichter

    Publicat 2017
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  10. 10
    Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study

    Adults with immune thrombocytopenia who switched to avatrombopag following prior treatment with eltrombopag or romiplostim: A multicentre US study per Hanny Al‐Samkari, Debbie Jiang, Terry Gernsheimer, Howard A. Liebman, Susie Lee, Matthew Wojdyla, Michael Vredenburg, Adam Cuker

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  11. 11
    Evaluation of bleeding and thrombotic events during long‐term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)

    Evaluation of bleeding and thrombotic events during long‐term use of romiplostim in patients with chronic immune thrombocytopenia (ITP) per Terry Gernsheimer, James N. George, Louis M. Aledort, Michael D. Tarantino, U. K. Sunkara, Ding‐Ding Guo, Janet L. Nichol

    Publicat 2010
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim

    Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim per Douglas B. Cines, Terry Gernsheimer, Jeffrey S. Wasser, Bertrand Godeau, Drew Provan, Roger M. Lyons, Ivy Altomare, Xuena Wang, Angela Lopez

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME)

    RhIG for the treatment of immune thrombocytopenia: consensus and controversy (CME) per Jenny M. Despotovic, Michele P. Lambert, Jay H. Herman, Terry Gernsheimer, Keith R. McCrae, Michael D. Tarantino, James B. Bussel

    Publicat 2011
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  14. 14
    Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia

    Platelet production and platelet destruction: assessing mechanisms of treatment effect in immune thrombocytopenia per Sarah Barsam, Bethan Psaila, Marc Forestier, Lemke K. Page, Peter A. Sloane, Julia T. Geyer, Glynis O. Villarica, Mary Ruisi, Terry Gernsheimer, Jürg H. Beer, James B. Bussel

    Publicat 2011
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study

    Rilzabrutinib <i>versus</i> placebo in adults and adolescents with persistent or chronic immune thrombocytopenia: LUNA 3 phase III study per David J. Kuter, James B. Bussel, Waleed Ghanima, Nichola Cooper, Terry Gernsheimer, Michele P. Lambert, Howard A. Liebman, Michael D. Tarantino, Michelle Lee, Hailing Guo, Ahmed Daak

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Response of Steroid-Refractory Acute GVHD to α 1 -Antitrypsin

    Response of Steroid-Refractory Acute GVHD to α 1 -Antitrypsin per A. Mario Marcondes, David M. Hockenbery, Marina Lesnikova, Charles A. Dinarello, Ann E. Woolfrey, Terry Gernsheimer, Mahmoud Loghman‐Adham, David Gelmont, Barry E. Storer, John A. Hansen, H. Joachim Deeg

    Publicat 2016
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  17. 17
    Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccination

    Thrombocytopenia following Pfizer and Moderna <scp>SARS‐CoV</scp>‐2 vaccination per Eun‐Ju Lee, Douglas B. Cines, Terry Gernsheimer, Craig M. Kessler, Marc Michel, Michael D. Tarantino, John W. Semple, Donald M. Arnold, Bertrand Godeau, Michele P. Lambert, James B. Bussel

    Publicat 2021
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial

    Prophylactic tranexamic acid in patients with hematologic malignancy: a placebo-controlled, randomized clinical trial per Terry Gernsheimer, Siobhan P. Brown, Darrell J. Triulzi, Nigel S. Key, Nahed El Kassar, Heather Herren, Jacqueline N. Poston, Michael Boyiadzis, Brandi Reeves, Subodh Selukar, Monica B. Pagano, Scott S. Emerson, Susanne May

    Publicat 2022
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

    Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients per Sherrill J. Slichter, Kathryn Davis, H Enright, Hayden G. Braine, Terry Gernsheimer, Kuo Jang Kao, Thomas S. Kickler, Edward B. Lee, Janice G. McFarland, Jeffrey McCullough, Glenn E. Rodey, Charles A. Schiffer, Robert D. Woodson

    Publicat 2005
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium

    2015 proceedings of the National Heart, Lung, and Blood Institute's State of the Science in Transfusion Medicine symposium per Steven L. Spitalnik, Darrell J. Triulzi, Dana V. Devine, Sunny Dzik, Anne F. Eder, Terry Gernsheimer, Cassandra D. Josephson, Daryl J. Kor, Naomi L.C. Luban, Nareg H. Roubinian, Traci Heath Mondoro, Renhao Li, Shimian Zou, Simone A. Glynn

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: